Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study

Journal of Clinical Neuroscience

Volumn 15, Issue 5, 2008, Pages 576-577

  Etminan, Mahyar ^a   Carleton, Bruce C ^b,c,d   Samii, Ali ^e,f  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Seattle VA Parkinson Disease Research Education and Clinical Center   (United States)

Author keywords

Apoptosis; Inflammation; Neuroprotection; NSAID; Parkinson disease

Indexed keywords

AMANTADINE; BROMOCRIPTINE; LEVODOPA; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE;

ADULT; ARTICLE; COLOMBIA; CONFIDENCE INTERVAL; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRITISH COLUMBIA; CANADA; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK;

EID: 41549133855     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.02.095     Document Type: Article

References (7)

1. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10 Suppl. 1 (2004) S3-S7
2. Hald A., and Lotharius J. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?. Exp Neurol 193 (2005) 279-290
3. Schneeweiss S., Maclure M., Carleton B., et al. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. BMJ 328 (2004) 560
4. Chen H., Zhang S.M., Hernan M.A., et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60 (2003) 1059-1064
5. Chen H., Jacobs E., Schwarzschild M.A., et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol 58 (2005) 963-967
6. Ton T.G., Heckbert S.R., Longstreth Jr. W.T., et al. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Mov Disord 21 (2006) 964-969
7. Hernan M.A., Logroscino G., and Garcia Rodriguez L.A. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology 66 (2006) 1097-1099